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Hemodynamic optimization in severe trauma: 
a systematic review and meta-analysis
REVIEW ARTICLE
INTRODUCTION
Trauma is the most common cause of mortality and morbidity in adults 
younger than 40 years old, accounting for significant ‘life years’ lost through 
premature death and disability. Strategies to improve the outcomes of 
trauma victims are therefore imperative.(1) Hemorrhagic shock associated 
with major trauma leads to a decrease in global oxygen delivery and vital 
organ perfusion. In addition to the initial insult of the trauma, subsequent 
surgical interventions place increased physiological demands on the patient. 
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Objective: Severe trauma can be 
associated with significant hemorrhagic 
shock and impaired organ perfusion. We 
hypothesized that goal-directed therapy 
would confer morbidity and mortality 
benefits in major trauma.
Methods: The MedLine, Embase 
and Cochrane Controlled Clinical Trials 
Register databases were systematically 
searched for randomized, controlled trials 
of goal-directed therapy in severe trauma 
patients. Mortality was the primary 
outcome of this review. Secondary 
outcomes included complication rates, 
length of hospital and intensive care 
unit stay, and the volume of fluid and 
blood administered. Meta-analysis was 
performed using RevMan software, and 
the data presented are as odds ratios for 
dichotomous outcomes and as mean 
differences (MDs) and standard MDs 
for continuous outcomes.
Results: Four randomized, controlled 
trials including 419 patients were 
analyzed. Mortality risk was significantly 
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reduced in goal-directed therapy-treated 
patients, compared to the control group 
(OR=0.56, 95%CI: 0.34-0.92). Intensive 
care (MD: 3.7 days 95%CI: 1.06-6.5) 
and hospital length of stay (MD: 3.5 days, 
95%CI: 2.75-4.25) were significantly 
shorter in the protocol group patients. 
There were no differences in reported 
total fluid volume or blood transfusions 
administered. Heterogeneity in reporting 
among the studies prevented quantitative 
analysis of complications.
Conclusion: Following severe 
trauma, early goal-directed therapy 
was associated with lower mortality 
and shorter durations of intensive care 
unit and hospital stays. The findings 
of this analysis should be interpreted 
with caution due to the presence of 
significant heterogeneity and the small 
number of the randomized, controlled 
trials included.
DOI: 10.5935/0103-507X.20140061
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Inability to meet the demand for oxygen delivery results 
in an anaerobic metabolism, accumulation of metabolic 
waste products, and eventually organ failure.(2)
The hemodynamic management of hypovolemic 
shock secondary to trauma can be divided into 3 distinct 
phases.(3) The first phase includes the period from injury 
to definitive surgical/radiological management and 
hemostasis. The second phase describes the immediate 
postoperative period, and the third phase encompasses 
the period in the intensive care unit (ICU) that follows 
definitive surgical care.
The first phase usually occurs during the pre- 
and early hospital periods. Early initiation of fluid 
resuscitation and rapid control of hemorrhage limit 
the duration of the first stage of trauma.(2) The use of a 
‘hypotensive resuscitation’ strategy in penetrating torso 
injuries has been associated with significant reductions 
in blood product requirements, fluid administration, 
postoperative coagulopathy and death.(4,5) However, 
there are no clear benefits of hypotensive resuscitation 
strategies in blunt trauma or in the presence of 
concomitant brain injury.
The second and third phases usually occur during 
the postoperative period in the ICU. Systemic 
inflammatory response syndrome (SIRS) associated 
with the initial trauma and subsequent surgery increases 
the oxygen demand. Failure to increase global oxygen 
delivery to match the oxygen deficit resulting from 
major surgery and trauma has been associated with 
increased incidences of organ failure and death.(6)
Pioneering observational studies have found that 
survivors of severe trauma and high-risk surgery were 
consistently able to achieve higher values of cardiac 
index and global oxygen delivery, compared with non-
survivors.(7,8) Hemodynamic values of survivors have 
therefore been used as targets of resuscitation in landmark 
studies by Shoemaker et al.(7) and Fleming et al.,(8) resulting 
in improved outcomes.
Several further trials have added to a now strong 
body of evidence suggesting that the use of goal-directed 
therapy (GDT) is associated with improved outcomes 
in high-risk surgical patients.(9-13) Protocolized 
goal-managed care has also been shown to improve 
outcomes in patients with sepsis(14) and in potential 
organ donors.(15) Similarities exist between patients 
undergoing major surgery and those undergoing major 
trauma, including the SIRS response and associated 
increased oxygen demand. However, evidence 
supporting the use of GDT in trauma patients has 
been limited. We investigated the effects on mortality 
of GDT following major trauma. Secondary outcomes 
included complication rates, hospital and ICU length 
of stay and volumes of fluids and blood administered.
METHODS
We performed this systematic review and 
meta-analysis following pre-specified criteria, using the 
PRISMA guidelines.(16)
Eligibility criteria
Only studies involving severe trauma patients 
were included. Severe trauma was defined as the 
presence of an injury severity score (ISS) of 15 or 
greater.(17,18) Randomized, controlled trials (RCT) 
reporting mortality and complications were included. 
GDT was defined as the use of hemodynamic 
monitoring and therapies to achieve pre-determined 
hemodynamic endpoints during trauma resuscitation 
and the immediate postoperative phase. Studies were 
included if they used hemodynamic optimization 
following a clear protocol, with step-by-step instructions 
for the clinician to provide interventions based on data 
obtained by hemodynamic monitors.
Burns, head injuries, pediatric populations and 
studies including other (non-trauma) critically ill 
patients were excluded.
Information sources and search strategy
MedLine (via Ovid), Embase (via Ovid) and 
the Cochrane Controlled Clinical Trials Register 
(CENTRAL, issue 5 of 2012) were searched for 
suitable studies. No date restrictions were applied to 
MedLine or CENTRAL. Embase was restricted to 
2009-2013.(19) Search terms were entered into the 
databases using a Cochrane highly sensitive search 
strategy(20) (Appendix 1), and these terms included 
‘goal-directed therapy, hemodynamic, optimization, goal 
oriented, goal targeted, cardiac output, cardiac index, 
oxygen delivery, oxygen consumption, cardiac volume, 
stroke volume, fluid therapy, fluid loading, supranormal, 
trauma, traumatic and injury’. We defined ‘supranormal’ 
physiological targets as a DO2L of >600mL/min/m
2 or a 
cardiac index >4.5L/min/m2.
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Two of the authors (CC, NA) independently 
screened titles and abstracts to exclude non-relevant 
studies. Full-text articles were then appraised against 
the inclusion criteria. Data were extracted from the 
selected studies using a pre-designed data collection 
form, by the same two authors (CC, NA). A third 
author (MC) resolved discrepancies arising from the 
data collection.
Methodological quality assessment
The included RCTs were analyzed for 
methodological quality using the scale designed by 
Jadad et al.(21) This scale appraises RCTs in terms 
of the methods used for random assignment and 
blinding and the flow of patients in the trial. The 
scale ranges from a score of 0 (lowest quality) to 5 
(highest quality). We did not exclude studies based 
on their Jadad scores.
Outcomes analysis
Hospital mortality was the primary outcome 
measurement of this study. Secondary outcomes were 
hospital and ICU length of stay, complication rates, 
and volumes of fluids and blood administered.
Statistical analysis
Dichotomous outcomes are reported as odds 
ratios (OR) using a Mantel Haenszel random effects 
method (with 95% confidence intervals [95%CI]). 
Differences in continuous outcomes are reported 
using a random-effects inverse variance model, 
as the mean difference (MD) and standard mean 
difference (SMD) when individual studies report 
outcomes using different scales.(20) P values were two 
tailed and considered to be statistically significant 
if <0.05. The chi-square test and between-study 
variance τ2 were used to assess heterogeneity with a 
statistical significance value for heterogeneity set at 
a p value of <0.1. Inconsistency was assessed using 
the I2 methodology and was considered to be high 
if >40%.(22) The statistical analyses were performed 
using RevMan software, version 5.1 (Cochrane Rev 
manager; 2012).
RESULTS
Study populations
The search strategy retrieved 4920 studies. 
Following screening of titles and abstracts, 305 
references were identified as potentially relevant to 
hemodynamic optimization in trauma. Further review 
of the abstracts against our inclusion criteria produced 
196 titles with potential for further analysis. After 
reviewing these abstracts, 29 full-text titles were then 
assigned for further analysis. Twenty-three studies were 
excluded because they were not RCT. A total of 6 RCT 
were identified. Of these, one RCT was excluded on 
the basis of including a mixed population of critically 
ill patients with and without trauma,(23) and another 
was excluded because the hemodynamic goals did not 
differ in the treatment and control groups.(24) Four 
titles were identified as RCTs suitable for statistical 
analysis(8,25-27) (Figure 1).
Figure 1 - Flow diagram of search process and study selection as suggested 
by the preferred reporting items for systematic reviews and meta-analysis 
(PRISMA). RCT - randomized controlled trials.
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The year of publication ranged from 1992 to 2007, 
and the study sizes varied between 67 and 162 patients. 
A total of 419 patients were included in the analysis, 
with 203 in the GDT protocol group and 216 in the 
control group. The 4 studies analyzed were single-center 
trials and included patients with severe trauma (ISS>15) 
and significant blood loss (>2000mL). The median Jadad 
score of the included studies was 2 (Table 1).
Description of studies
Bishop et al.(25) and Fleming et al.(8) used the 
pulmonary artery catheter (PAC), whereas Chytra 
et al.(26) used the oesophageal Doppler monitor (ODM), 
and Velmahos et al.(27) used thoracic bioimpedance 
with or without the PAC. In 3 of the 4 studies, 
supranormal hemodynamic DO2I and cardiac index 
were targeted in the GDT group using PAC-guided 
fluid and inotrope therapy. The other study, utilizing 
the ODM, used fluids to achieve a specific corrected 
flow time (FTc>0.35s) and to optimize stroke volume. 
All of the studies commenced the optimization 
protocol within 12 hours of admission to the hospital 
or surgery (Table 2).
Mortality
All 4 of the RCT included reported mortality as a 
primary outcome. A total of 36 patients (17.7%) in 
the GDT treatment group and 61 patients (28%) in 
the control group died. Overall, there was a significant 
reduction in the relative risk of mortality in the GDT 
group (OR 0.56; 95%CI: 0.34-0.92; p=0.02, I2=3%), 
compared to the control group (Figure 2).
Intensive care and Hospital length of stay
Hospital and ICU length of stay were reported in 
all 4 of the trials. There was significant heterogeneity 
between the included trials for these outcomes. Patients 
receiving hemodynamic optimization had significantly 
shorter ICU (MD 3.7 days, 95%CI: 1.06-6.5, p=0.006, 
I2=98%) (Figure 3) and hospital length of stay (MD 
3.5 days, 95%CI: 2.75-4.25, p<0.00001, I2=44%) 
(Figure 4) than the patients in the control group.
Table 1 - Randomized clinical trials of goal-directed therapy in severe trauma patients
Author/year Patients 
protocol 
group 
(N)
Patients 
control 
group 
(N)
Monitor 
protocol 
group
Type of 
intervention
Goals protocol 
group
Goals control 
group
Mortality 
protocol 
group 
N (%)
Mortality 
control group 
N (%)
Jadad 
score
Fleming, 
1992(8)
33 34 PAC Fluids + 
Dobutamine
DO2I>670mL/min/m
2 
VO2>166mL/mim/m
2 
CI>4.5L/min/m2
SBP>120mmHg 
HR<110bpm 
Hb>10g/dL 
UO 30-50mL/h 
CVP 8-12mmHg
8 (24) 15 (44) 1
Bishop, 
1995(25)
50 65 PAC Fluids + 
Dobutamine
DO2I>670mL/min/m
2 
VO2>166mL/mim/m
2 
CI>4.5L/min/m2 
Hb up to 14g/dL
SBP>120mmHg 
HR<110bpm 
Hb>10g/dL 
UO 30-50mL/h 
CVP 8-12mmHg
9 (18) 24 (37) 1
Chytra, 
2007(26)
80 82 ODM Fluids FTC>0.35, SV CVP 12-15mmHg 
MAP>65 
SpO2>95,% 
HR<100bpm 
UO>1mL/kg/h 
T 37º C 
Hb>8.5
Velmahos, 
2000(27)
40 35 Thoracic 
bioimpedance/
PAC
Fluids ± 
inotropes ± 
vasopressors
SBP>100mmHg 
Hct>30% 
UO>1mL/lg/h 
BE<-3 
CI>4.5L/min/m2 
PtcO2/FiO2>200 
If PAC DO2I>600mL/min/m
2 
VO2I>170mL/min/m
2
SBP>100mmHg 
Hct>30% 
UO>1mL/lg/h 
BE<-3 
CI>4.5L/min/m2 
PtcO2/FiO2>200 
If PAC DO2I>450mL/min/m
2 
VO2I>130mL/min/m
2
6 (15) 4 (11) 3
PAC - pulmonary artery catheter; DO2I - oxygen delivery index; VO2 - oxygen consumption; CI - cardiac index; SBP - systolic blood pressure; HR - heart rate; bpm - beats per minute; 
Hb - hemoglobin; UO - urinary output; CVP - central venous pressure; ODM - oesophageal Doppler monitor; FTC - flow time corrected; MAP - mean arterial pressure; SpO2 - oxygen saturation; 
T - temperature; Hct - hematocrit; BE - base excess; PtcO2/FiO2 - ratio of transcutaneous oxygen tension to fractional inspired oxygen.
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Figure 2 - Effects of goal-directed therapy in protocol group versus control group on mortality.
Table 2 - Fluid and blood administration volumes
Author/year Timing 
intervention
Period of volume 
infusion reported
Total fluids protocol 
group (mL) 
(mean±SD)
Total fluids control 
group (mL) 
(mean±SD)
RBC transfused 
protocol group 
(mean±SD)
RBC transfused 
control group 
(mean±SD)
Fleming, 1992(8) Within 6 hours after 
surgery/admission
Admission to 48 hours 
post-operatively
Crystalloid: 
13,247±1,377 
Colloid: 4097±552
Crystalloid: 
16,943±1,558 
Colloid: 2,528±781
5,848±920mL 6,423±1,234mL 
p<0.01
Bishop, 1995(25) Within 6 hours after 
surgery or 12 hours 
after admission
Admission to 48 hours 
post-operatively
Crystalloid: 
9,065±772 
Colloid: 3,038±391
Crystalloid: 
9,197±649 
Colloid: 1,352±330 
p<0.00001
4,304±575mL 2,715±513mL 
p<0.0001
Chytra, 2007(26) ICU admission 12 hours 
post-operatively
Crystalloid: 
1,667±426 
Colloid: 1,293±300
Crystalloid: 
1,334±320 
p=0.38 
Colloid: 682±322 
p<0.0001
814±228mL 833±340mL
Velmahos, 2000(27) On arrival to hospital 24 hours from admission 14,000±6,500 13,000±6,000 11±10.5 units 11±7 units
Ml - milliliters; ICU - intensive care unit.
Figure 3 - Effects of goal-directed therapy in protocol group versus control group on intensive care unit length of stay.
Complications and organ failure
Quantitative analysis of complications was not 
possible due to variations in the reporting of data 
among the studies. Three of the 4 studies demonstrated 
reductions in complication rates associated with early 
GDT.(8,25,26) Fleming showed a reduction in the number 
of organ failure events per patient in the protocol 
group, compared with the control group (0.79±0.68 
versus 1.74±1.64; p=0.05).(10) Similar results were 
demonstrated by Bishop et al. (0.74±0.28 versus 
1.68±0.28, p<0.05 for the protocol group compared 
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Figure 4 - Effects of goal directed therapy in protocol group versus control group on hospital length of stay.
to the control group, respectively).(25) In the study by 
Chytra, the relative risk of infectious complications was 
lower among patients in the GDT group, compared 
to the control group (RR 0.5491, 95%CI: 0.31-0.95; 
p=0.032).(26) In contrast to the other studies, Velmahos 
et al. found no differences in complication rates between 
the treatment and control groups.(27)
Red cell transfusion and fluid administration 
requirements
Quantitative analysis showed significant 
heterogeneity between the trials and did not demonstrate 
a significant difference in blood transfusion requirements 
between the GDT and control groups. (SMD=0.58, 
95%CI: -0.74-1.89, p=0.39, I2=97%) (Figure 5). Only the 
study by Bishop et al. reported a statistically significantly 
greater red blood cell transfusion requirement in the 
GDT group (4,304±575mL), compared to the control 
group (2,715±513mL, p<0.0001)(25) (Table 2). Similarly, 
there were no significant differences in the total volume 
of fluid administered during the studies (SMD=0.65, 
95%CI: -0.84-2.15 p=0.39, I2=98%) (Figure 6). Bishop 
et al. reported however, a significantly greater volume 
of colloid administered in the GDT group, compared 
to the control group (3,038±391mL versus 1,352±330, 
respectively, p<0.00001). Similarly, Chytra et al.(26) 
reported a significantly greater mean volume of colloid 
administered to the treatment group, compared to the 
control group (1,667±426mL versus 682±322mL, 
p<0.0001, respectively) (Table 2).
DISCUSSION
In this meta-analysis, GDT was associated with a 
beneficial effect on mortality in patients with major 
trauma. Three of the 4 studies used the PAC, because 
most of the studies were conducted prior to widespread 
use of minimally invasive cardiac output monitors. The 
potential benefits of the newer hemodynamic monitors 
used to assess the adequacy of resuscitation in trauma 
patients(28,29) warrant further RCTs.
The evidence supporting perioperative GDT for 
the high-risk surgical patient has shown that, when 
hemodynamic optimization is initiated early and 
delivered using a clearly defined protocol,(9,30) morbidity 
(and for high-risk groups also mortality) is decreased 
postoperatively. This review was performed to ascertain 
whether GDT during the second and third phases of 
major trauma conferred any benefit.
Fluid resuscitation that forms part of GDT, might 
increase the risks of intra-abdominal hypertension 
and abdominal compartment syndrome among 
trauma patients undergoing GDT.(31) However, we 
found no significant difference in the total volume of 
fluid administered, although firm conclusions were 
not possible due to differences in study duration. In 
addition, none of the studies included in this review 
included data on the incidence of intra-abdominal 
hypertension.
There might be concerns that an increase in global 
oxygen delivery could increase perfusion pressure, 
resulting in more bleeding complications and greater 
transfusion requirements. Although we found no 
differences in transfusion requirements between the 
GDT and control groups of patients, none of the studies 
reported the final hemoglobin concentrations between 
treatment and control groups, and there were significant 
differences in the transfusion protocols among the studies. 
Differences in transfusion requirements in the treatment 
and control groups should therefore be interpreted with 
caution. Furthermore, GDT should be considered only 
after adequate hemostasis has been achieved.
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Figure 5 - Effects of goal directed therapy in protocol group versus control group on blood transfusion requirements.
Figure 6 - Effects of goal directed therapy in protocol group versus control group on total volume of fluids administered.
The main limitations of this meta-analysis were the 
small number of studies and the lack of recent studies, 
with the publication dates spanning more than 20 
years. Significant heterogeneity among the included 
studies was present and was accounted for by applying 
the more conservative random effects model in the 
meta-analysis. Although it was not possible to perform 
a quantitative analysis of morbidity or organ failure, 
most of the studies reviewed suggested a trend toward 
a beneficial effect of GDT in trauma. Furthermore, 
we acknowledge that the definitions and coding of 
complications were likely to vary among the studies. We 
analyzed the data extracted from studies, rather than 
the data of individual patients. Not all of the studies 
included were of a high-quality design, as reflected by 
the median Jadad score of 2.
Because surgical techniques, peri-operative care, 
and patient selection have been refined over the years, 
the overall mortality of high-risk surgical patients 
has improved. This change was recently evaluated 
in a meta-analysis of 29 peri-operative GDT trials 
performed between 1995 and 2008.(9) There was an 
approximate halving of mortality rates in the control 
group every decade (29.5%, 13.5%, 7%). As such, the 
applicability of historical trials to current-day practice 
might not be valid. Due to the small number of studies, 
it was not possible to ascertain the effects of time on 
the mortality rates of trauma patients, and up-to-date 
RCTs are required.
CONCLUSION
Hemodynamic optimization using a pre-defined 
protocol and started early in the course of the 
perioperative period of patients with severe traumatic 
injury was associated with a mortality benefit and might 
also reduce the incidence of organ failure. The current 
results should be interpreted with caution due to the 
significant statistical heterogeneity present and the small 
number of randomized controlled trials included. Further 
randomized controlled trials, set within current trauma 
and hemodynamic optimization practices, are desirable.
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Objetivo: O trauma grave pode associar-se a ocorrência 
de importante choque hemorrágico e ao comprometimento 
da perfusão dos órgãos. Formulamos a hipótese de que o 
tratamento direcionado por objetivo conferiria benefícios em 
termos de morbidade e mortalidade, em casos graves de trauma.
Métodos: Realizamos uma busca sistemática nas bases 
de dados MedLine, Embase e Cochrane Controlled Clinical 
Trials Register com relação a pacientes vítimas de trauma 
grave. A mortalidade foi o desfecho primário dessa revisão. 
Os desfechos secundários incluíram taxas de complicações, 
duração da permanência no hospital e na unidade de terapia 
intensiva, e o volume de fluidos administrados. A metanálise 
foi realizada utilizando o programa de computador RevMan, 
e os dados apresentados são as odds ratios (OR) para desfechos 
dicotomizados e as diferenças médias e diferenças médias padrão 
para desfechos contínuos.
Resultados: Foram analisados quatro estudos clínicos 
randomizados e controlados, que incluíram 419 pacientes. 
O risco de mortalidade foi significantemente reduzido nos 
pacientes com tratamento direcionado por objetivo, em 
comparação ao grupo controle (OR=0,56; IC95%: 0,34-0,92). 
A duração da permanência na unidade de terapia intensiva 
(DM: 3,7 dias; IC95%: 1,06-6,5) e no hospital (DM: 3,5 dias; 
IC95%: 2,75-4,25) foi significantemente mais curta no grupo 
de pacientes do grupo tratado conforme o protocolo. Não 
houve diferenças nos relatos relativos a volume total de fluidos 
infundidos e a transfusões sanguíneas. A heterogeneidade nos 
relatos entre os estudos impediu uma análise quantitativa das 
complicações.
Conclusão: Após a ocorrência de trauma grave, o uso 
precoce de tratamento direcionado por objetivo se associou 
com mortalidade mais baixa e com menos dias de permanência 
na unidade de terapia intensiva e no hospital. Os achados 
desta análise devem ser interpretados com cautela, em razão 
da importante heterogeneidade e do número pequeno de 
estudos clínicos randomizados e controlados, que foram 
incluídos na análise.
RESUMO
Descritores: Ferimentos e lesões; Índices de gravidade 
do trauma; Choque hemorrágico; Hidratação/métodos; 
Hemodinâmica/fisiologia
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Appendix 1 - Search strategies
1. MedLine database (OVID interface): the Cochrane highly sensitive search 
strategy was used:
#1. randomized Controlled Trials as Topic/
#2. randomized controlled trial/
#3. random Allocation/
#4. double Blind Method/
#5. single Blind Method/
#6. clinical trial/
#7. controlled clinical trial.pt.
#8. randomized controlled trial.pt.
#9. multicenter study.pt.
#10. clinical trial.pt.
#11. exp Clinical Trials as topic/
#12. or/1-11
#13. (clinical adj trial$).tw.
#14. ((singl$ or doubl$ or treb$ or tripl$) adj (blind$3 or mask$3)).tw.
#15. randomly allocated.tw.
#16. (allocated adj2 random$).tw.
#17. or/13-16
#18. 12 or 17
#19. case report.tw.
#20. letter/
#21. historical article/
#22. or/19-21
#23. 18 not 22
#24. exp trauma/
#25. trauma.tw.
#26. trauma.mp.
 20. Higgins JP, Green S, editors. Cochrane Handbook for Systematic Reviews 
of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane 
Collaboration 2011 [cited 2012 April 11]. Available from http://www.
cochrane-handbook.org
 21. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan 
DJ, et al. Assessing the quality of reports of randomized clinical trials: is 
blinding necessary? Control Clin Trials. 1996;17(1):1-12.
 22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency 
in meta-analyses. BMJ. 2003;327(7414):557-60. Review.
 23. Durham RM, Neunaber K, Mazuski JE, Shapiro MJ, Baue AE. The use of 
oxygen consumption and delivery as endpoints for resuscitation in critically 
ill patients. J Trauma. 1996;41(1):32-9; discussion 39-40.
 24. Ivatury RR, Simon RJ, Islam S, Fueg A, Rohman M, Stahl WM. A 
prospective randomized study of end points of resuscitation after major 
trauma: global oxygen transport indices versus organ-specific gastric 
mucosal pH. J Am Coll Surg. 1996;183(2):145-54.
 25. Bishop MH, Shoemaker WC, Appel PL, Meade P, Ordog GJ, Wasserberger 
J, et al. Prospective, randomized trial of survivor values of cardiac index, 
oxygen delivery, and oxygen consumption as resuscitation endpoints in 
severe trauma. J Trauma. 1995;38(5):780-7.
 26. Chytra I, Pradl R, Bosman R, Pelnár P, Kasal E, Zidková A. Esophageal Doppler-
guided fluid management decreases blood lactate levels in multiple-trauma 
patients: a randomized controlled trial. Crit Care. 2007;11(1):R24.
 27. Velmahos GC, Demetriades D, Shoemaker WC, Chan LS, Tatevossian R, Wo 
CC, et al. Endpoints of resuscitation of critically injured patients: normal or 
supranormal? A prospective randomized trial. Ann Surg. 2000;232(3):409-18.
 28. Burns JM, Sing RF, Mostafa G, Huynh TT, Jacobs DG, Miles WS, et al. 
The role of transesophageal echocardiography in optimizing resuscitation 
in acutely injured patients. J Trauma. 2005;59(1):36-40; discussion 40-2.
 29. Kohli-Seth R, Neuman T, Sinha R, Bassily-Marcus A. Use of 
echocardiography and modalities of patient monitoring of trauma patients. 
Curr Opin Anaesthesiol. 2010;23(2):239-45. Review.
 30. Cecconi M, Corredor C, Arulkumaran N, Abuella G, Ball J, Grounds RM, 
et al. Clinical review: Goal-directed therapy-what is the evidence in surgical 
patients? The effect on different risk groups. Crit Care. 2013;17(2):209.
 31. Balogh Z, McKinley BA, Cocanour CS, Kozar RA, Valdivia A, Sailors RM, 
et al. Supranormal trauma resuscitation causes more cases of abdominal 
compartment syndrome. Arch Surg. 2003;138(6):637-42; discussion 642-3.
Continue...
... continuation
#27. 24 or 25 or 26
#28. exp trauma$/
#29. Trauma$.tw.
#30. Trauma$.mp
#31. 28 or 29 or 30
#32. Exp injury/
#33. Injury.tw.
#34. Injury.mp.
#35. 32 or 33 or 34
#36. 27 or 31 or 35
#37. exp goal directed/ or goal directed.tw. or goal directed.mp.
#38. exp goal oriented/ or goal oriented.tw. or goal oriented.mp.
#39. exp goal target/ or goal target.tw. or goal target.mp.
#40. exp cardiac output/ or cardiac output.tw. or cardiac output.mp.
#41. exp cardiac index/ or cardiac index.tw. or cardiac index.mp.
#42. exp oxygen delivery/ or oxygen delivery.tw. or oxygen delivery.mp.
#43. exp oxygen consumption/ or oxygen consumption.tw. or oxygen 
consumption.mp
#44. exp cardiac volume/ or cardiac volume.tw. or cardiac volume.mp.
#45. exp stroke volume/ or stroke volume.tw. or stroke volume.mp.
#46. exp fluid therapy/ or fluid therapy.tw. or fluid therapy.mp.
#47. exp fluid loading/ or fluid loading.tw. or fluid loading.mp.
#48. exp fluid administration/ or fluid administration.tw. or fluid administration.mp.
#49. exp optimization/ or optimization.tw. or optimization.mp.
#50. exp optimization/ or optimisation.tw. or optimisation.mp.
#51. exp supranormal/ or supranormal.tw. or supranormal.mp.
#52. exp lactate/ or lactate.tw. or lactate.mp.
#53. exp extraction ratio/ or extraction ratio.tw. or extraction ratio.mp.
Continue...
Hemodynamic optimization in severe trauma 406
Rev Bras Ter Intensiva. 2014;26(4):397-406
#54. 37 or 38 or 39 or 40 or 41or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 
or 50 or 51 or 52 or 53
#55. 23 and 36 and #54
2. Embase (OVID interface):
#1. Clinical Trial/
#2. Randomized controlled trial/
#3. Randomization/
#4. Single blind procedure/
#5. Double blind procedure/
#6. Crossover procedure/
#7. Placebo/
#8. Randomi?ed controlled trial$.tw.
#9. Rct.tw.
#10. Random allocation.tw.
#11. Random allocated.tw
#12. Allocated randomly.tw.
#13. (allocated adj2 random).tw.
#14. Single blind$.tw.
#15. Double blind$.tw.
#16. Placebo$.tw
#17. Prospective study/
#18. Or/1-17
#19. Case study/
#20. Case report.tw.
#21. Abstract report/or letter/
#22. Or/19-21
#23. 18 not 22
#24. trauma
#25. exp trauma/or trauma
#26. traum$
#27. 24 or 25 or 26
#28. Injury
#29. exp injury/or injury
#30. 27 or 28
#31. 26 or 29
#32. exp heart/ or heart.mp.) and output.mp.
#33. exp heart output/ or heart output.mp.
#34. goal directed
#35. goal oriented
#36. goal target
#37. exp heart index/ or heart index.mp.
#38. exp heart stroke volume/ or heart stroke volume.mp.
... continuation
#39. exp oxygen consumption/ or oxygen consumption.mp.
#40. oxygen delivery.mp.
#41. exp fluid therapy/
#42. fluid administration.mp
#43. fluid loading.mp.
#44. hemodynamic.mp
#45. supranormal.mp.
#46. optimisation.mp.
#47. optimization.mp.
#48. exp lactate/
#49. extraction ratio.mp
#50. 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 
or 44 or 45 or 46 or 47 or 48
#51. 23 and 30 and 49
3. Cochrane clinical trials database (CENTRAL):
#1. trauma in Trials
#2. Trauma* in Trials
#3. traumatic* in Trials
#4. Injury* in Trials
#5. 1 OR 2 OR #3 OR 4
#6. cardiac near output* in trials
#7. cardiac near volume* in Trials
#8. cardiac near index* in Trials
#9. oxygen near delivery* in Trials
#10. oxygen near consumption* in Trials
#11. supranormal* in Trials
#12. stroke near volume* in Trials
#13. fluid near therapy* in Trials
#14. fluid near administration* in Trials
#15. fluid near loading* in Trials
#16. extraction near ratio* in Trials
#17. lactate* in Trials
#18. goal near directed* in Trials*
#19. goal near oriented* in Trials
#20. goal near target* in Trials
#21. Hemodynamic near optimization* in trials
#22. Hemodynamic near optimization * in trials
#23. Optimization* in trials
#24. Optimisation* in trials
#25. #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 
OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 
OR #23 OR #24
#26. #5 AND#25
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